The Third ILAC-WADA Communiqué issued with respect to the ILAC-WADA cooperation regarding the WADA anti-doping laboratories was published on 1 April 2021. The Communique is for the attention of all accreditation bodies involved in the accreditation of WADA anti-doping laboratories in accordance with ISO/IEC 17025 and is available from https://ilac.org/about-ilac/partnerships/international-partners/wada/ under Communiqués.

WADA anti-doping laboratories are required to maintain dual accreditation by demonstrating compliance with two international standards, namely:
      i) ISO/IEC 17025 General requirements for the competence of testing and calibration laboratories; and
      ii) WADA’s International Standard for Laboratories (ISL).

The ISL requires that the ISO/IEC 17025 accreditation of WADA anti-doping laboratories be granted by accreditation bodies (ABs) that are signatories to the ILAC Mutual Recognition Arrangement (MRA), and this accreditation serves as the prerequisite for WADA’s laboratory accreditation.

This Third ILAC-WADA Communiqué provides comprehensive information on the roles and responsibilities, as agreed between ILAC and WADA, in regard to the sharing of information between WADA and any ILAC MRA Signatory AB that accredits an anti-doping laboratory.